HIMS & HERSPriority claimed from 21/08/2020; Application No. : 90130458 ;United States of America (Class 5)

The trademark application number 4695631 is currently marked as "DRAFT" in the official trademark registry.

The trademark application number 4695631 is owned by HIMS, INC..

Trademark application number 4695631 is filed under Class 5, which relates to the specified goods and services.

The trademark agent associated with application number 4695631 is LEXORBIS.

Yes, trademark application number 4695631 was published in Journal No. 1973.

Trademark application number 4695631 relates to "Medicated hair care preparations; pharmaceutical preparations used to treat eyelashes; pharmaceutical preparations for the treatment of hair loss; medicated dandruff shampoo; pharmaceutical preparations for the treatment of hirsutism and to retard hair growth; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of premature ejaculation vitamins; prenatal vitamins; medicated skin care preparations; medicated mouth care and treatment preparations; cold sore treatment preparations; dietary and nutritional supplements; dietary and nutritional supplements, namely, sleep supplements; dietary and nutritional supplements namely, recovery supplements; dietary and nutritional supplements, namely, protein supplements; powdered nutritional supplement concentrate; powdered nutritional supplement drink mix; powdered food supplement drink mix containing protein; dietary and nutritional supplements, namely, dehydroepiandrosterone (DHEA) supplements; dietary and nutritional supplements, namely, weight loss and weight management supplements; dietary and nutritional supplements, namely, nootropics; dietary and nutritional supplements, namely, energy supplements; dietary and nutritional supplements, namely, testosterone supplements; medical diagnostic test kits for testing the presence of medical conditions and levels of substances, namely, pregnancy, STDs, AMH, diabetes, hyperhidrosis and other laboratory testable blood markers; pharmaceutical preparations for treating psoriasis and eczema; medicated acne treatment preparations; pharmaceutical preparations, namely, smoking cessation preparations; pharmaceutical preparations for birth control; fertility enhancement preparations; menopause treatment preparations; menstrual symptom treatment preparations; hormone replacement preparations and substances; estrogen preparations; transdermal patches featuring vitamins; pharmaceutical and medicinal preparations for use in the treatment of herpes, vulvar and vaginal atrophy, sleep disorders, acid reflux, allergies, depression, cardiovascular disorders and cholesterol reduction; medicinal preparations for treating anxiety; antifungal preparations; medicinal preparations used as narcotic antagonists; personal lubricants; vaginal moisturizers; sexual arousal and sexual stimulant preparations; sexual care products, namely, oral vitamin supplements; pain relief medication; analgesic preparations; analgesics, namely, naproxen sodium, ibuprofen, and acetaminophen; medical diagnostic test kits for testing the presence of medical conditions, namely, SARS-CoV-2 coronavirus".